Download Medical Notes on Evaluate Vantage Pharma, Biotech and Medtech Half-Year Review 2020

Evaluate Vantage Pharma, Biotech and Medtech Half-Year Review 2020 Medical Notes

About This Presentation

Description:The coronavirus pandemic has been the driving force shaping the biopharma and medtech sectors over the first half of 2020. And, while much of the fallout has been predictable, certain events and trends have surprised. Check out the Evaluate Vantage Pharma, Biotech and Medtech Half-Year Review 2020 for more details

Tags:Pharma, Biotech, Medtech Half-Year Review, 2020 , coronavirus, pandemic

Published on: Jul 30, 2020 | Views : 1800 | Downloads : 0

Comment

Transcript

No transcript available for this presentation

User Presentation
Related Presentations

High-Performance Pharma Brand Plans - The 5 Pitfalls to avoid

By: MattB
Views: 2378

FDA Role in Regulation of Cannabis Products

By: MattB
Views: 1328

United Nations Office on Drugs and Crime (UNODC) World Drug Report 2020 - Booklet 4.5

By: MattB
Views: 1906

Generics and Biosimilars Industry Response to COVID-19

By: MattB
Views: 1350

Taming big Pharma

By: MattB
Views: 1381

Evaluate Vantage Pharma, Biotech & Medtech 2019 in Review

By: MattB
Views: 1476

COVID-19: Super-charging Drug Development in the Race for a Cure

By: docshare
Views: 1324

Pharma 2020 Taxing times ahead

By: KhushbuSG
Views: 1477

Evaluate Vantage 2020 Preview – A Report on Pharmaceutical Industry

By: MattB
Views: 2507

EvaluatePharma pharmaceutical industry world review 2019 and outlook 2024

By: MattB
Views: 1449

MattB

About : An experienced pharma professional managing sales, marketing and brand management of top global pharma products Presently leading a team of experts in the development and execution of pharma eCommerce strategies that support GSK products to HCP customers.
Occupation : Medical Professional
Specialty : Other Health Professionals
Country : United States of America
Website :

HEALTH A TO Z